Reporting Manager
RA Capital Management, L.P.
Symbol
RYTM
Shares outstanding
67,341,788 shares
Disclosed Ownership
6,666,837 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:41:42 UTC
Date of event
31 Dec 2025
Previous filing
14 Aug 2025

Sponsored

Quoteable Key Fact

"RA CAPITAL MANAGEMENT, L.P. disclosed 9.9% ownership in RHYTHM PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RYTM) on 31 Dec 2025."

Quick Takeaways

  • RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G/A for RHYTHM PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RYTM).
  • Disclosed ownership: 9.9%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 14 Aug 2025.
  • Current filing was accepted on 17 Feb 2026, 16:41.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 9.9% 6,666,837 0 6,666,837 /s/ Peter Kolchinsky By Peter Kolchinsky, Authorized Signatory
Peter Kolchinsky 9.9% 6,666,837 0 6,666,837 /s/ Peter Kolchinsky Peter Kolchinsky
Rajeev Shah 9.9% 6,666,837 0 6,666,837 /s/ Rajeev Shah Rajeev Shah
RA Capital Healthcare Fund, L.P. 9.9% 6,666,837 0 6,666,837 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager